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ABSTRACT
Background: Adequate gestational weight gain (GWG) is essential
for healthy fetal growth. However, in low- and middle-income
countries, where malnutrition is prevalent, little information is
available about GWG and how it might be modified by nutritional
status and interventions.
Objective: We describe GWG and its associations with fetal
growth and birth outcomes. We also examined the extent to which
prepregnancy BMI, and preconception and early weight gain modify
GWG, and its effects on fetal growth.
Methods: This was a secondary analysis of the Women First Trial,
including 2331 women within the Democratic Republic of Congo
(DRC), Guatemala, India, and Pakistan, evaluating weight gain from
enrollment to ∼12 weeks of gestation and GWG velocity (kg/wk)
between ∼12 and 32 weeks of gestation. Adequacy of GWG velocity
was compared with 2009 Institute of Medicine recommendations,
according to maternal BMI. Early weight gain (EWG), GWG
velocity, and adequacy of GWG were related to birth outcomes using
linear and Poisson models.
Results: GWG velocity (mean ± SD) varied by site: 0.22 ± 0.15
kg/wk in DRC, 0.30 ± 0.23 in Pakistan, 0.31 ± 0.14 in Guatemala,
and 0.39 ± 0.13 in India, (P <0.0001). An increase of 0.1 kg/wk
in maternal GWG was associated with a 0.13 cm (95% CI: 0.07,
0.18, P <0.001) increase in birth length and a 0.032 kg (0.022,
0.042, P <0.001) increase in birth weight. Compared to women
with inadequate GWG, women who had adequate GWG delivered
newborns with a higher mean length and weight: 47.98 ± 2.04 cm
compared with 47.40 ± 2.17 cm (P <0.001) and 2.864 ± 0.425 kg
compared with 2.764 ± 0.418 kg (P <0.001). Baseline BMI, EWG,
and GWG were all associated with birth length and weight.
Conclusions: These results underscore the importance of adequate
maternal nutrition both before and during pregnancy as a potentially
modifiable factor to improve fetal growth. Am J Clin Nutr
2021;0:1–9.
Keywords: gestational weight gain, developing countries, fetal
development, nutrition during pregnancy, infant nutrition disorders,
malnutrition, low birth weight
Introduction
Adequate maternal nutrition is an important component of the
“first 1000 days,” a critical time to promote healthy child growth.
Gestational weight gain (GWG) is one measure of maternal
nutrition status, and appropriate GWG is essential for healthy
fetal growth and birth outcomes (1–3). Inappropriate (inadequate
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or excessive) GWG might have a lasting impact beyond the
neonatal period, by influencing growth in the offspring through-
out early childhood (4, 5). Despite the association between GWG
and healthy fetal growth, information is limited with regards to
GWG and postnatal growth in low- and middle-income countries
(LMICs) where childhood malnutrition is a major cause of
mortality. In these contexts, women might not be weighed as part
of routine antenatal care, counseled about healthy GWG, nor have
access to adequate food to modify nutritional intake (6).
The Women First Trial evaluated the impact of a maternal
nutrition supplement initiated either before or early in pregnancy
on length at birth in 4 LMICs (7). This study showed an
improvement in birth length and weight when mothers were
given the nutritional supplement compared with a control arm.
The nutritional supplement might have influenced GWG among
participants and might have a differential effect based on maternal
nutritional status, as measured by maternal weight and BMI
at enrollment, prior to conception (8–11). GWG has not been
widely studied in low-resource settings and might be an important
mediator of the effects nutritional supplements have on fetal
growth.
In these secondary analyses of participants in the Women First
Trial, we describe GWG and its associations with fetal growth
and birth outcomes in 4 LMICs. We describe GWG within each
country by baseline maternal nutritional status and the receipt
of nutrition interventions. We explore the interactions between
baseline BMI status and GWG. We also evaluate how GWG
might mediate the effects of maternal nutrition interventions.
Methods
The details of the Women First Trial have been previously
reported (12). Briefly, this was an individually randomized,
nonmasked, multisite, controlled efficacy trial conducted in
research sites in the Democratic Republic of Congo (DRC),
Guatemala, India, and Pakistan. The primary aim of this trial was
to identify the effects of maternal nutrition supplementation at 2
different time points: preconception (Arm 1), at the end of the
first trimester (Arm 2), and no supplementation (Arm 3, control)
on birth length. Women were included if they were aged 16–35
y, parity 0–5, and expecting to become pregnant. We excluded
nulliparous women who were unwilling to deliver in a hospital
and those who were severely anemic. Women were randomly
assigned by permuted block design with stratification by research
cluster, allocating women in a 1:1:1 ratio within the 3 treatment
arms (12).
Women who were randomly assigned to Arm 1 started a small
quantity, lipid-based micronutrient supplement (supplement 1)
from the time of randomization until delivery. Women who
received ≥3 mo of supplement prior to conception were included.
Women randomly assigned to Arm 2 received the same lipid-
based micronutrient supplement, beginning at the end of the first
trimester through to delivery. Women in Arms 1 or 2 that had
a BMI <20 kg/m2 or suboptimal GWG, based on the Institute
of Medicine (IOM) recommendations, received an additional
protein-energy nutrition supplement (supplement 2) when they
started nutrition supplementation. Women randomly assigned to
Arm 3 did not receive nutrition supplementation from the study
at any point.
Trained assessment teams measured women and newborns
using standardized equipment and procedures. Maternal height
and weight were measured at enrollment. We obtained maternal
weight measurements at 2 additional times during gestation,
∼12 weeks and 32 weeks of gestation. This report includes all
women from the Women First Trial who had 2 measurements
for weight and for whom birth outcomes were available. We
calculated baseline BMI based on height and weight measured
at enrollment, prior to conception. The time interval between
enrollment and conception varied, therefore, we evaluated the
change in weight rather than the weight gain velocity in the
preconception and early gestation interval. We defined baseline
measurements for BMI as underweight (BMI <18.5 kg/m2),
normal weight (18.5–24.9), overweight (25.0–29.9), and obese
(≥30) (13). As a small percentage (4% of the overall sample)
of mothers were obese, we combined obese mothers with
overweight mothers in the analyses.
Newborn anthropometry was measured within 48 h after
delivery. Newborn weight was measured in triplicate using a
seca 334 electronic scale, and newborn length was measured
using a neonatal stadiometer (Ellard Instrumentation Ltd). We
defined low birth weight (LBW) as a newborn weight <2500 g.
Gestational age was determined by ultrasound when available,
using crown-rump length measurements within the first trimester.
Ultrasound dating was not available for all participants, therefore,
we excluded data from women without ultrasound dating from
outcome analyses that depended upon precise assignment of
gestational age. No ultrasounds were performed in the DRC.
We defined GWG velocity as the change in weight (kg)
between the 2 gestational weight measurements, divided by the
number of weeks between the 2 measurements. We chose this
method because it was not dependent on the precise assessment
of gestational age at the time of the measurements. Secondarily,
we repeated the analyses on a subset of women for whom
gestational dating by ultrasound was performed, using alternate
definitions for GWG. For this subset, we assigned each woman a
Z-score based on her GWG and number of weeks gestation using
INTERGROWTH-21st standards (14). For these analyses, we
defined anthropometry at birth by length-for-age Z-score (LAZ)
and weight-for-age Z-score (WAZ), based on INTERGROWTH-
21st standards (15). We examined distributions of the variables
and conducted diagnostic tests to assess model assumptions (e.g.,
normal distribution).
We evaluated the “adequacy” of GWG velocity based on the
2009 IOM recommendations for GWG velocity in the second
and third trimesters (4). We chose the IOM recommendations
since there are no consensus recommendations for adequate
weight gain during pregnancy for populations in LMICs. We
categorized a woman as having inadequate GWG velocity if
her GWG velocity was below the lower limits of the IOM
recommendations, or <0.51 kg/wk for an underweight woman
(baseline BMI <18.5); <0.42 kg/wk for a normal weight woman
(baseline BMI 18.5–24.9); <0.28 kg/wk for an overweight
woman (baseline BMI 25.0–29.9); and <0.22 kg/wk for an obese
woman (baseline BMI ≥30). We categorized a woman as having
“excess” GWG velocity if her GWG velocity was above the
upper limits of the IOM recommendations, or >0.58 kg/wk for an
underweight woman; >0.50 kg/wk for a normal weight woman;
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For the statistical analyses, we began by conducting ANOVA
to compare mean GWG velocity by treatment arm and demo-
graphic characteristics (site, baseline BMI, age, and parity). We
conducted chi-square tests of treatment arm and demographic
characteristics by adequacy of GWG. We then fitted mixed effect
regression models of the outcomes by GWG velocity, using linear
models to estimate adjusted mean differences for continuous
outcomes (newborn weight and length) and Poisson models to
estimate adjusted relative risks for categorical outcomes (LBW
and preterm birth). Each model controlled for treatment arm,
demographic characteristics, and weight gain from baseline to 12
weeks of gestation, and accounted for clustering of participants
by sampling clusters within sites. We performed sensitivity
analyses by including and excluding adolescent mothers in the
models.
We evaluated the effect of weight gain from baseline (prior to
conception) to 12 wk (termed “preconception and early weight
gain, or EWG”) and conducted bivariable analyses to determine
if EWG was associated with GWG or birth outcomes [length,
weight, preterm birth, LBW, or small-for-gestational age (SGA)].
A conditional linear regression model was used to examine the
independent association for the different weight gain intervals
and birth outcomes (16).
Next, the associations between adequate GWG and birth
outcomes were examined, and whether these associations varied
by baseline BMI category (underweight, normal weight, and
overweight/obese). We compared outcomes for women with
adequate, inadequate, or excessive weight gain, using t-tests
for continuous outcomes and chi-square tests for categorical
outcomes. Then, we fitted mixed effect regression models to
compare outcomes by adequacy of weight gain controlling for
treatment arm and demographics and accounting for sampling
clusters. These analyses were conducted for all participants
and separately by BMI category. The descriptive analyses and
regression models were conducted using SAS version 9.4 (SAS
Institute).
Finally, we conducted mediation analyses to test whether
GWG served as a mediator between treatment arm and outcomes.
As treatment arm is a multicategory nominal variable, we used
the approach described by Hayes and Preacher for mediation
analyses with multicategorical independent variables (17). The
mediation analyses were conducted in the structural equation
modeling framework with Mplus version 8.3 (Muthén &
Muthén), using bootstrapping to determine CIs.
The Women First Trial was approved by the Colorado Multiple
Institutional Review Board, University of Colorado, the local
and/or national ethics committees at each research site, and the
data coordinating center. All participants provided verbal and
written consent to be included in the trial. The Women First
Trial was registered at clinicaltrials.gov as NCT01883193 and the
study protocol is published online (18).
Results
We report 2331 women from the Women First Trial (95%
of women with the primary outcome) from research sites in
DRC, Guatemala, India, and Pakistan (Figure 1). Roughly equal
numbers of women within each site were randomly assigned
to each study arm (Table 1). Mean (± SD) baseline BMI for
FIGURE 1 Consolidated Standards of Reporting Trials (CONSORT) di-
agram of participant flow. Overall screening, randomization, and obtainment
of primary outcome. DRC, Democratic Republic of Congo; MTP, medical
termination of pregnancy.
the sample was 21.5 ± 4.1, however, the mean varied from
19.7 ± 2.9 in the Pakistani site to 25.5 ± 4.2 in the Guatemalan
site (Table 1). Overall, 23% of the sample was underweight based
on baseline BMI. However, this percentage also varied by site,
with only 1% underweight in the Guatemalan site and 35% and
37% underweight in the Pakistani and Indian sites, respectively.
Only 4% of the overall sample was obese, based on baseline BMI,
but this percentage also varied by site, with 1% obese in the DRC,
Indian, and Pakistani sites, and 14% obese in the Guatemalan site.
Maternal age distribution was similar in all sites and 21% of the
sample were nulliparous (Table 1).
GWG velocity varied by site, P <0.001 (Table 2). The DRC
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TABLE 1 Baseline maternal demographics combined and by site
Characteristic
All sites
(n = 2331) DRC (n = 444)
Guatemala
(n = 611) India (n = 590) Pakistan (n = 686)
Treatment Arm1
Arm 1 756 (32) 143 (32) 179 (29) 192 (33) 242 (35)
Arm 2 825 (35) 162 (36) 225 (37) 201 (34) 237 (35)
Arm 3 750 (32) 139 (31) 207 (34) 197 (33) 207 (30)
Maternal weight, kg 48.8 ± 9.0 50.2 ± 7.8 54.0 ± 9.8 45.9 ± 8.4 45.7 ± 7.1
Baseline BMI, kg/m2
(mean ± SD)
21.5 ± 4.1 20.6 ± 2.6 25.5 ± 4.2 20.0 ± 3.4 19.7 ± 2.9
Baseline BMI categories
Underweight (<18.5) 542 (23) 81 (18) 6 (1) 217 (37) 238 (35)
Normal (18.5–24.9) 1394 (60) 344 (77) 310 (51) 325 (55) 415 (61)
Overweight (25.0–29.9) 293 (13) 15 (3) 210 (34) 40 (7) 28 (4)
Obese (≥30) 101 (4) 4 (1) 84 (14) 8 (1) 5 (1)
Age, y (mean ± SD) 23.3 ± 4.2 22.8 ± 4.5 24.3 ± 4.4 21.9 ± 3.4 23.7 ± 4.1
Age, y
<20 475 (20) 114 (26) 91 (15) 146 (25) 124 (18)
20–24 962 (41) 167 (38) 242 (40) 323 (55) 230 (34)
25+ 894 (38) 163 (37) 278 (46) 121 (21) 332 (48)
Parity
Nulliparous 486 (21) 92 (21) 42 (7) 148 (25) 204 (30)
Primi/multiparous 1845 (79) 352 (79) 569 (93) 442 (75) 482 (70)
Data presented as n (%) unless otherwise noted.
1Maternal participants in Arm 1 started the intervention ≥3 mo prior to conception; Arm 2 started the same intervention at ∼12 weeks of gestation; and
Arm 3 (control) received no study intervention.
DRC, Democratic Republic of Congo.
kg/wk and the Indian site had the highest GWG velocity at
0.39 ± 0.13 kg/wk. There was no significant difference noted in
GWG velocity by treatment arm (P = 0.10). We noted differences
in GWG velocity by baseline BMI category, age, and parity.
Women with lower baseline BMIs had higher GWG velocities:
0.33 ± 0.17 kg/wk for underweight women; 0.31 ± 0.18
kg/wk for normal weight women; and 0.28 ± 0.18 kg/wk
for overweight/obese (P <0.001). GWG velocity also differed
by maternal age: 0.29 ± 0.19 kg/wk for women aged<20 y;
0.33 ± 0.17 kg/wk for women aged 20–24 y, and 0.30 ± 0.18
kg/wk for women aged 25 y or older (P <0.001). Nulliparous
women had lower GWG velocity (0.29 ± 0.20 kg/wk) than
multiparous women (0.31 ± 0.18 kg/wk) (P <0.05). Results were
similar when repeated without adolescent mothers included in the
model.
The interval of EWG varied from 8 to 116 wk (1 participant had
a pregnancy that occurred before 12 wk, which was a protocol
violation) based on the timing of conception after baseline
measurements were obtained. After adjusting for baseline
demographic features (maternal age, parity, and baseline BMI),
women gained a mean (95% CI) of 0.86 kg (0.54, 1.19 kg) in Arm
1, 0.08 (−0.24, 0.40) in Arm 2, and 0.31 (−0.02, 0.65) in Arm 3,
(control). Women in Arm 1 had more EWG than women in Arm
2 (P <0.001) and Arm 3 (P = 0.003).
EWG was associated with GWG velocity [regression coeffi-
cient 0.01 (95% CI: −0.02, −0.01), P <0.001]. The independent
associations of interval weight gain and birth length and weight
are shown in Table 3. Higher maternal weight at baseline
and larger maternal weight gain in the EWG period were
associated with longer birth lengths and larger birth weights.
This association pattern was demonstrated among underweight,
normal weight, overweight, and obese mothers. EWG was
associated with birth length [RR 0.04 (95% CI: 0.02, 0.07),
P <0.001], weight [RR 0.01 (95% CI: 0.01, 0.02), P <0.001],
LBW [RR 0.97 (95% CI: 0.95, 0.99), P = 0.003], and SGA
[RR 0.97 (95% CI: 0.95, 0.99), P = 0.006], after controlling for
baseline demographics.
We identified 74% of women as having inadequate GWG, 10%
with adequate weight gain, and 15% of women with excessive
weight gain. Inadequate weight gain was common in all sites,
ranging from 63% of women in Guatemala to 93% of women
in the DRC (Table 2). Excessive weight gain was uncommon in
the DRC site (4% of women), but more common in the Indian
(19%) and Guatemalan (24%) sites. There was no significant
difference in adequacy of GWG by treatment arm (P = 0.086)
and no differences in adequacy of GWG based on maternal age
or parity.
The theoretical framework describing GWG as the exposure
in a series of models controlling for pertinent confounders is
displayed in Figure 2. After controlling for treatment arm,
age, parity, and EWG, an increase in GWG was positively
associated with increases in newborn length and weight across
all sites. Based on our regression model, an increase of 0.10
kg/wk of maternal GWG was associated with a 0.13 cm (95%
CI: 0.07, 0.18, P <0.001) increase in birth length and a
0.032 kg (95% CI: 0.02, 0.04, P <0.001) increase in birth
weight. We report an 8% reduction in LBW with an increase
of 0.1 kg/wk GWG velocity [RR 0.92 (95% CI: 0.88, 0.96),
P <0.001].
When women without ultrasound-based gestational age
assignment were excluded from analyses (Figure 1) and
INTERGROWTH-21st standards were used to evaluate GWG
(using INTERGROWTH-21st Z-scores for maternal weight gain)
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TABLE 2 Gestational weight gain velocity and adequacy by maternal demographics
Gestational weight gain velocity1 (kg/wk) Adequacy of gestational weight gain (n [%])






(n = 345) P value
Site
DRC 440 0.216 ± 0.154 <0.001 410 (93) 13 (3) 17 (4) <0.001
Guatemala 610 0.307 ± 0.144 386 (63) 77 (13) 146 (24)
India 589 0.392 ± 0.125 396 (67) 79 (13) 114 (19)
Pakistan 680 0.298 ± 0.228 539 (79) 73 (11) 68 (10)
Treatment Arm2
Arm 1 753 0.307 ± 0.178 0.10 584 (78) 65 (9) 104 (14) 0.086
Arm 2 822 0.319 ± 0.180 588 (72) 99 (12) 134 (16)
Arm 3 744 0.299 ± 0.182 559 (75) 78 (10) 107 (14)
Baseline BMI
categories3
Underweight 541 0.328 ± 0.172 <0.001 483 (89) 22 (4) 36 (7) <0.001
Normal weight 1384 0.310 ± 0.184 1058 (76) 176 (13) 150 (11)
Overweight/obese 393 0.277 ± 0.175 190 (48) 44 (11) 159 (40)
Age, y
<20 474 0.292 ± 0.195 <0.001 366 (77) 44 (9) 64 (14) 0.62
20–24 955 0.326 ± 0.172 700 (73) 107 (11) 147 (15)
25+ 890 0.300 ± 0.180 665 (75) 91 (10) 134 (15)
Parity
Nulliparous 482 0.294 ± 0.196 0.038 376 (78) 40 (8) 66 (14) 0.13
Primi/multiparous 1837 0.313 ± 0.176 1355 (74) 202 (11) 279 (15)
Data presented as mean ± SD or n (%). ANOVA were used for weight gain comparisons and chi-square tests for adequacy of weight gain comparisons.
1Gestational weight gain velocity was defined as the change in weight (kg) between 2 maternal weight measurements, divided by the number of weeks
between the 2 measurements. Maternal weight measurements were recorded at ∼12 and 32 weeks of gestation.
2Maternal participants in Arm 1 started the intervention ≥3 mo prior to conception; Arm 2 started the same intervention at ∼12 weeks of gestation; and
Arm 3 (control) received no study intervention.
3Baseline BMI categories were defined based on the maternal weight at enrollment in the study, prior to conception: Underweight (<18.5), Normal
Weight (18.5–24.9), and Overweight/Obese (≥25).
DRC, Democratic Republic of Congo.
INTERGROWTH-21st Z-scores), we observed similar associ-
ations (Supplemental Table 1). Using INTERGROWTH-21st
standards, we noted differences in GWG velocity by site,
treatment arm, baseline BMI category, and age but not parity
(Supplemental Table 2). An increase of 1 SD in maternal weight
gain Z-score was associated with an increase of 0.06 SD in
newborn LAZ (P <0.01) and an increase of 0.05 SD in newborn
WAZ (P <0.01). Whereas no significant difference in SGA [adj.
RR 0.96 (95% CI: 0.92, 1.00)] was observed, we found a reduced
risk of preterm birth [adj. RR 0.87 (95% CI: 0.79, 0.86)] with
increasing gestational weight Z-scores (Supplemental Tables 1
and 2).
Newborn length differed among women with inadequate,
adequate, and excessive GWG velocity (Figure 3). Women
who had adequate and excessive GWG delivered newborns
with higher mean newborn lengths (47.98 cm and 48.06
cm, respectively) than women with inadequate GWG (47.40
cm, P <0.001). The positive association between adequate
and excessive GWG and newborn length was most notable
among normal weight women. Women who had adequate and
excessive GWG delivered newborns with higher mean newborn
weights (2.864 kg and 2.901 kg, respectively) than women with
inadequate GWG (2.764 kg, P <0.001) (Figure 4). The positive
association between adequate GWG and newborn weight was
observed for underweight women, but not normal weight or
overweight/obese women.
We did not find a significant mediation effect between
treatment arm and length or weight outcomes by GWG velocity
between Arm 1 and the controls, Arm 3 (data not shown). We
observed statistically significant mediation effects between Arms
2 and 3 with regards to length [coefficient 0.021 (95% CI: 0.003,
0.047)] and weight [coefficient 0.006 (95% CI: 0.001, 0.012)]
by GWG velocity. However, we repeated these analyses using
the subset of participants for which gestational age was known
and using INTERGROWTH-21st standards for LAZ and WAZ,
and observed no significant mediating effect on LAZ [coefficient
0.009 (95% CI: −0.001, 0.027)] or WAZ [coefficient 0.011 (95%
CI: 0.000, 0.027)].
Discussion
We report significant associations between baseline BMI,
EWG, and GWG velocity with the outcomes of newborn length
and weight. These associations varied by baseline maternal
BMI status. For all maternal weight categories, adequate GWG,
according to the IOM recommendations, was associated with an
8% reduction in LBW, significant differences in newborn birth
length, and for underweight women, birth weight. Although these
effects are small, the positive association between GWG velocity
and fetal growth underscores the importance of optimal maternal
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TABLE 3 Newborn length and weight by baseline maternal weight status, early weight gain (EWG, baseline to 12 wk), and gestational weight gain (GWG,
12–32 wk)
BMI category1 Length, cm Weight, kg
Maternal weight2 B (95% CI) P B (95% CI) P
All participants
Baseline weight 0.06 (0.05, 0.07) <0.001 0.014 (0.012, 0.016) <0.001
EWG 0.09 (0.06, 0.12) <0.001 0.021 (0.016, 0.025) <0.001
GWG 0.09 (0.07, 0.12) <0.001 0.021 (0.016, 0.026) <0.001
Underweight
Baseline weight 0.12 (0.07, 0.17) <0.001 0.021 (0.013, 0.030) <0.001
EWG 0.13 (0.07, 0.19) <0.001 0.027 (0.016, 0.038) <0.001
GWG 0.15 (0.09, 0.21) <0.001 0.030 (0.020, 0.041) <0.001
Normal weight
Baseline weight 0.09 (0.07, 0.11) <0.001 0.019 (0.015, 0.023) <0.001
EWG 0.08 (0.05, 0.11) <0.001 0.020 (0.014, 0.026) <0.001
GWG 0.08 (0.05, 0.12) <0.001 0.020 (0.013, 0.026) <0.001
Overweight/Obese
Baseline weight 0.04 (0.01, 0.06) 0.002 0.006 (0.000, 0.011) 0.019
EWG 0.08 (0.03, 0.13) 0.002 0.016 (0.005, 0.026) 0.004
GWG 0.06 (0.01, 0.12) 0.020 0.013 (0.001, 0.024) 0.032
Note: Regression coefficients (B) are based on a linear mixed effects regression model accounting for site, study arm, maternal age, and parity.
1Baseline BMI categories were defined based on the maternal weight at enrollment into the study, prior to conception. Categories were defined as:
Underweight (<18.5 kg/m2), Normal Weight (18.5–24.9), and Overweight/Obese (≥25).
2Baseline weight is the maternal weight at enrollment into the study. Early weight gain (EWG) is the change in maternal weight (kg) between the
interval of baseline and 12 wk. Gestational weight gain (GWG) is the change in maternal weight (kg) between 12 and 32 weeks of gestation.
birth size, especially noting the apparent benefit of preconception
weight status and EWG.
In our low-resource settings where many women are under-
nourished, their preconception nutritional status might affect
the development and growth of the placenta and fetus through
alterations in placental blood flow, alterations in the epigenetic
state, or fetal programming (8, 10, 19). Low maternal BMI
may also limit the effectiveness of nutrition supplementation
(8). These outcomes of fetal growth might be influenced
and improved with adequate GWG during pregnancy. In our
study, underweight women or women with low GWG were
offered additional protein-energy supplementation (supplement
2), which started prior to conception for women in Arm 1, and
not before ∼11 weeks of gestation for Arm 2. However, only
11% of underweight women had adequate GWG despite the
availability of this additional supplementation, emphasizing the
challenge of alleviating chronic malnutrition during pregnancy
using a relatively acute dietary intervention, especially in settings
with food insecurity. In addition, the majority of the women in
this study consumed diets with marginal intakes of energy and
protein for pregnancy, and the additional study supplements may
not have achieved optimal intakes (20).
FIGURE 2 Theoretical framework. Framework used to incorporate interventions and variables into statistical models to determine relations between
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FIGURE 3 Adjusted mean differences of infant length by adequacy of gestational weight gain (GWG). Values are mean differences in infant weight (kg)
between those with adequate or excessive compared with inadequate GWG after accounting for site, study arm, maternal age, parity, and weight gain from
baseline to 12 weeks of gestation using a generalized linear mixed effects model. Weight categories are defined based on BMI: underweight (BMI <18.5),
normal weight (BMI 18.5–24.9), and overweight/obese (BMI ≥25). Numbers of women with inadequate GWG by baseline BMI are: underweight (n = 471),
normal weight (n = 1020), and overweight (n = 181).
We observed similar GWG velocity by treatment arm. This
finding differs from the findings of the parent trial that showed
modestly higher weight gain among women in Arm 1 than
in the other 2 arms (7). We assume the differences in our
report are related to our definition of GWG velocity for these
analyses. In the parent trial, GWG was reported as absolute
weight gain (kg) during pregnancy. In this study, we describe
GWG as a function of time between measurements, thereby
describing GWG velocity (kg/wk). This finding could have also
been influenced by the manner in which we provided nutritional
supplementation during the course of the Women First Trial,
in which participating women were closely monitored with
Higher for adequate/Excessive GWG
FIGURE 4 Adjusted mean differences of infant weight by adequacy of gestational weight gain (GWG). Values are mean differences in infant length (cm)
between those with adequate or excessive compared with inadequate GWG after accounting for site, study arm, maternal age, parity, and weight gain from
baseline to 12 weeks of gestation using a linear mixed effects model. Weight categories are defined based on BMI: underweight (BMI <18.5), normal weight
(BMI 18.5–24.9), and overweight/obese (BMI ≥25). Numbers of women with inadequate GWG by baseline BMI are: underweight (n = 471), normal weight
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monthly weight checks to assess gestational weight gain. If
women receiving the primary micronutrient fortified supplement
(supplement 1) experienced suboptimal weight gain during the
study, they were given additional supplementation (supplement
2) to improve GWG, which could have led to similar GWG
among women in Arms 1 and 2. We also recognize that GWG
is on the causal pathway between the nutrition supplementation
and fetal growth and could mediate the relation; however, our
mediation analysis did not show a significant effect.
We observed an association among preconception and EWG,
treatment arm, GWG velocity, and birth outcomes. Women in
Arm 1 had greater weight gain in the EWG period, coinciding
with the timing of initiation of nutrition supplementation
immediately after enrollment and randomization. During the
preconception interval, women in Arm 1 were provided the nu-
tritional intervention (micronutrients and modest calorie/protein
supplementation) and an additional protein-energy supplement
(supplement 2) if their weight was suboptimal (7). The mean
weight gain in the EWG period was small (mean 0.86 kg) among
women in Arm 1, controlling for other factors, but higher than
for women in Arms 2 and 3 who did not receive nutrition
supplementation.
Our study benefitted from the multicountry design within
LMICs and from the careful measurement of newborn anthro-
pometry and the inclusion of newborn length as a primary
outcome; however, we recognize some limitations. We are limited
by the timing of our assessment of GWG. Our last measurement
was at ∼32 weeks of gestation, and therefore did not include
potential influences of GWG during the final weeks of gestation.
We used GWG velocity as the measure of GWG. Although
GWG velocity is not consistent across the entire pregnancy, we
evaluated 2 time points that encompassed the second trimester
and the beginning of the third trimester, a period of rapidly
increasing GWG. Although this measure of GWG velocity
could have bias when evaluating preterm birth, we conclude
that our endpoint at 32 wk reduces but does not eliminate that
bias (20).
We were also limited by our inability to determine gestational
age among many participants. Although we used ultrasound to
confirm gestational dating in 3 sites when available, ultrasound
dating was unavailable in the DRC. Therefore, we are limited
in our ability to evaluate gestational-age-dependent growth vari-
ables among those women. However, when we limited our sample
to the participants with known gestational age and repeated the
analyses (Supplemental Tables 1 and 2), associations between
markers of GWG and newborn length and weight were similar.
For these supplemental analyses, we compared the observed
GWG among our participants to the INTERGROWTH-21st
GWG standard. Although the INTERGROWTH-21st standard
was created using normal weight women with initial weights
measured between 9 and 14 weeks of pregnancy, we applied it
to our cohort that included underweight, overweight, and obese
women. Similarly, references to evaluate adequacy of weight gain
in more austere settings in LMICs are not available. We used
the 2009 IOM recommendations for adequacy of GWG, but we
recognize that these recommendations might not be applicable in
low-resource settings.
In conclusion, maternal preconception BMI, maternal weight
gain between randomization ≥3 mo prior to conception and 12
weeks of gestation, and GWG velocity between ∼12 and 32
weeks of gestation were all independently associated with birth
length and weight. These findings underscore the importance of
adequate maternal weight status prior to conception and weight
gain during pregnancy. They also confirm the value of maternal
nutrition supplements initiated ≥3 mo prior to conception in
resource-poor populations in LMICs.
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